美国 · SEC FORM 4
Burning Rock Biotech Ltd
BNR · Nasdaq · CIK 0001792267 · Healthcare · Diagnostics & Research
内部人信号
1 位买方 · 7 条买入交易行 · $6.2M 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
- ⚠ Purchase activity is becoming less recent
- ✓ 角色得分高 · 买入者中职位最高的是：Director
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 60.8
- 60.8
- 60.7
- 60.7
- 60.6
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- +33.3%
- 3M
- +45.3%
- 6M
- -2.2%
- 12M
- +74.0%
波动率与流动性
- 波动率
- 122.1%
- Beta
- —
- 平均每日成交额
- USD 439,695
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- -10.3%
- ROE
- -10.3%
- 细分行业
- Diagnostics & Research
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：利润率, ROE · 财年截止日：2025-12-31 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 41,425
- 上期报告
- 39,415
- 日均成交量
- 41,873
- 回补天数
- ≤ 1.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-26 | Han Yusheng | 买入 (P) | Ordinary Shares (represented by American depositary shares) | 24,900 | USD 8.00 | USD 199,200 | SEC 申报 ↗ |
| 2026-06-24 | Han Yusheng | 买入 (P) | Ordinary Shares (represented by American depositary shares) | 250,000 | USD 8.00 | USD 2,000,000 | SEC 申报 ↗ |
| 2026-06-23 | Han Yusheng | 买入 (P) | Ordinary Shares (represented by American depositary shares) | 5,990 | USD 7.50 | USD 44,925 | SEC 申报 ↗ |
| 2026-06-22 | Han Yusheng | 买入 (P) | Ordinary Shares (represented by American depositary shares) | 104,650 | USD 7.45 | USD 779,642 | SEC 申报 ↗ |
| 2026-06-16 | Han Yusheng | 买入 (P) | Ordinary Shares (represented by American depositary shares) | 111,110 | USD 9.00 | USD 999,990 | SEC 申报 ↗ |
| 2026-06-12 | Han Yusheng | 买入 (P) | Ordinary Shares (represented by American depositary shares) | 210,000 | USD 9.25 | USD 1,942,500 | SEC 申报 ↗ |
| 2026-06-11 | Han Yusheng | 买入 (P) | Ordinary Shares (represented by American depositary shares) | 24,760 | USD 8.74 | USD 216,402 | SEC 申报 ↗ |
Form 4 申报证据
7 transaction lines in the latest 365-day window; 7 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-26 | Han Yusheng | 买入 (P) | Ordinary Shares (represented by American depositary shares) | 24,900 | USD 8.00 | USD 199,200 | SEC 申报 ↗ |
| 2026-06-24 | Han Yusheng | 买入 (P) | Ordinary Shares (represented by American depositary shares) | 250,000 | USD 8.00 | USD 2,000,000 | SEC 申报 ↗ |
| 2026-06-23 | Han Yusheng | 买入 (P) | Ordinary Shares (represented by American depositary shares) | 5,990 | USD 7.50 | USD 44,925 | SEC 申报 ↗ |
展开近期 Form 4 证据 (7 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-26 | Han Yusheng | 买入 (P) | Ordinary Shares (represented by American depositary shares) | 24,900 | USD 8.00 | USD 199,200 | SEC 申报 ↗ |
| 2026-06-24 | Han Yusheng | 买入 (P) | Ordinary Shares (represented by American depositary shares) | 250,000 | USD 8.00 | USD 2,000,000 | SEC 申报 ↗ |
| 2026-06-23 | Han Yusheng | 买入 (P) | Ordinary Shares (represented by American depositary shares) | 5,990 | USD 7.50 | USD 44,925 | SEC 申报 ↗ |
| 2026-06-22 | Han Yusheng | 买入 (P) | Ordinary Shares (represented by American depositary shares) | 104,650 | USD 7.45 | USD 779,642 | SEC 申报 ↗ |
| 2026-06-16 | Han Yusheng | 买入 (P) | Ordinary Shares (represented by American depositary shares) | 111,110 | USD 9.00 | USD 999,990 | SEC 申报 ↗ |
| 2026-06-12 | Han Yusheng | 买入 (P) | Ordinary Shares (represented by American depositary shares) | 210,000 | USD 9.25 | USD 1,942,500 | SEC 申报 ↗ |
| 2026-06-11 | Han Yusheng | 买入 (P) | Ordinary Shares (represented by American depositary shares) | 24,760 | USD 8.74 | USD 216,402 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | BNR |
| CIK | 0001792267 |
| 行业 | Healthcare |
| 细分行业 | Diagnostics & Research Yahoo Finance |
| SEC SIC | 8071 Services-Medical Laboratories |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 7 transaction lines from 2026-06-11 to 2026-06-26 7 P purchase lines · 0 S sale lines · 0 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.